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Abstract 
Circadian rhythms are driven by daily oscillations of gene expression. An important tool for studying 
cellular and tissue rhythms is the use of a gene reporter, such as bioluminescence from the reporter gene 
luciferase controlled by a rhythmically expressed gene of interest. Here we describe methods that allow 
measurement of bioluminescence from a freely-moving mouse housed in a standard cage. Using a 
LumiCycle In Vivo (Actimetrics), we determined conditions that allow detection of circadian rhythms of 
bioluminescence from the PER2 reporter, PER2::LUC, in freely behaving mice. We tested delivery of D-
luciferin via a subcutaneous minipump and in the drinking water. Further, we demonstrate that a synthetic 
luciferase substrate, CycLuc1, can support circadian rhythms of bioluminescence, even when delivered at 
a lower concentration than D-luciferin. We share our analysis scripts and suggestions for further 
improvements in this method. This approach will be straightforward to apply to mice with tissue-specific 
reporters, allowing insights into responses of specific peripheral clocks to perturbations such as 
environmental or pharmacological manipulations.  
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Circadian rhythms arise from cycles of gene expression that occur in cells throughout the body. These 
cellular rhythms can be observed using a transgenic mouse with a circadian clock promoter or protein, 
linked to a reporter that generates signal as fluorescence or bioluminescence. The mPer2Luc mouse, 
created in the laboratory of Joseph Takahashi (Yoo et al. 2004), has allowed many major advances in our 
understanding of circadian biology, largely through studies conducted using explant culture techniques. 
The transgene in this animal produces a fusion protein linking PERIOD2 (PER2) with firefly luciferase. 
Firefly luciferase, when provided with a substrate such as D-luciferin, will emit light (bioluminescence; for 
an overview, see (Shimomura 2012).  
Bioluminescence has several advantages compared to fluorescence for long-term studies, including low 
phototoxicity and very low background noise (Troy et al. 2004). Studies of bioluminescence in tissue 
explants can reveal cellular activity, but can currently only assess isolated tissues outside their natural 
physiochemical environment. Additionally, in some circumstances the time of dissection for tissue 
preparation can reset the phase of cellular circadian clocks (Noguchi et al. 2018, Leise et al. 2018), thereby 
limiting the comparison of circadian phase recorded in vitro to the preceding phase in vivo. More complex 
interactions between tissues are best studied within a living intact animal.  
To address these challenges, we and others have explored methods for recording bioluminescence in vivo. 
One approach is to use anesthetized animals, detecting bioluminescence using a camera-based system. 
This approach has been used to assess the phase of peripheral tissue rhythms (Tahara et al. 2012) but has 
the unavoidable disadvantage of repeated general anesthesia. Anesthesia has been shown to disrupt 
circadian rhythms in body temperature and in rest/activity cycles, and may inhibit photic entrainment of 
the circadian clock (Poulsen et al. 2018). The method also requires bioluminescence assessments at six to 
nine time points, each requiring experimenter presence, over 24 to 36 hours for a single circadian phase 
assessment. A second approach is to record bioluminescence from freely behaving mice, detecting light 
emission using sensitive photomultiplier tubes (PMTs). Here we build on the pioneering work from the 
Schibler laboratory (Saini et al. 2013) that demonstrated the feasibility of recording light emitted from a 
mouse in a specialized housing chamber, the “RT Biolumicorder” (LESA Technology). In their work, 
rhythmic signal was detected from bioluminescent reporters directed to the liver using viral transduction 
in hairless mice, as well as in mPer2Luc C57BL/6 mice with fur removed from the dorsal region. In addition 
to establishing feasibility of the method, the system was used to control food availability and provide 
lighting regimens for studies of entrainment. Some areas of further research are to develop a system that 
allows housing in standard cages, to test nonsurgical methods for delivery of D-luciferin, and to test 
synthetic luciferins that may offer increased sensitivity (Evans et al. 2014). 
We present here results from studies of PER2::LUC bioluminescence in C57BL/6 mice, recorded in 
standard housing cages within the “LumiCycle In Vivo” system (designed for these experiments by 
Actimetrics Inc.). We compare two methods of delivery for the substrate D-luciferin: delivery through 
drinking water, and using subcutaneous osmotic mini-pumps. Additionally, we assessed whether a 
synthetic luciferin, CycLuc1 (Evans et al. 2014), can offer advantages as a substrate in these experiments. 
In the course of this work we encountered several methodological challenges and addressed how they 
may be overcome. We believe that these methods could be widely adopted and could also be improved 
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through further innovation. Ultimately, we predict the field of circadian biology will benefit from 
expanded use of unrestrained, in vivo, bioluminescence recordings. 
Methods 
The LumiCycle In Vivo  
Bioluminescence was measured using the “LumiCycle In Vivo” system, designed by David Ferster 
(Actimetrics). The system can record luminescent emissions from freely behaving animals housed in a 
standard mouse cage placed within a light-tight chamber (Supplementary Figure S1). 
Each unit contained two PMTs (Hamamatsu H8259-01, selected for low dark counts and positioned for 
sensitivity across the cage area), and was equipped with programmable LED lights, and a high-capacity 
internal fan that provided 15 air changes per hour. A programmable shutter periodically blocked the PMTs 
and allowed the collection of dark counts. In the studies reported here, dark counts were measured every 
15 minutes by closing the shutter for 1 minute. Each dark-count value was subtracted from the counts 
recorded during the subsequent 14 minutes to obtain the background-corrected count values. This was 
necessary to remove the effect of external temperature fluctuations on PMT noise. Prior to this correction 
we observed noise highly correlated to temperature (R2= 0.96) and less so with humidity (R2=0.30). One 
degree Celsius of chamber ambient temperature increase was associated with an increase of circa 35 
counts/s. A chamber history for all recording units was collected, to monitor temperature, relative 
humidity, and light measures within each unit. Animal welfare was checked once a day at varied times 
using an infrared viewer (Carson OPMOD DNV 1.0), or goggles (Pulsar Edge Night Vision Goggles PL75095). 
Animals  
For studies conducted at Smith College, animals were bred in-house from founders obtained from Jackson 
Labs (JAX #006852). Homozygous mPer2Luc/Luc male and female mice were included in this study (Yoo et 
al. 2004), ranging in age from 4.5 to 8 months. We chose homozygous mice in order to maximize luciferase 
expression.  
IVIS imaging studies were conducted at the University of Massachusetts Medical School, and employed 
either FVB/NJ mice purchased from Jackson Laboratories and given intravenous injection of AAV9-CMV-
WTluc2 as previously described (Mofford et al. 2015) or, in separate studies, mice with a single copy of 
the Per2::LucSV allele (Welsh et al. 2004, Yoo et al. 2017). The latter mice are referred to as mPer2LucSV/+ 
to distinguish them from the homozygous mice used elsewhere. All animal studies were approved by the 
Institutional Animal Care and Use Committees of the appropriate institution. 
Delivery of substrates by subcutaneous osmotic mini-pump  
A delivery method that can provide continuous dosing is to use a subcutaneous osmotic mini-pump. Prior 
studies have reported mixed results with similar methods (Gross et al. 2007, Saini et al. 2013, Hamada et 
al. 2016). We determined that 100 mM was close to the limit of solubility for D-luciferin in our conditions 
and therefore tested this concentration in both 7-day and 14-day Alzet osmotic minipumps (models 1007D 
and 1002, respectively) to vary the rate of delivery (0.5 and 0.25 ul/h). 100 mM D-luciferin was prepared 
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in sterile 0.1 M sodium phosphate buffer (PB) and mixed on an Eppendorf ThermoMixer (Thermo Fisher 
Scientific, Waltham, MA) at 37° C for two minutes @ 1500 RPM. Following surgery to implant an osmotic 
mini-pump subcutaneously we allowed 3 days recovery before initiating bioluminescence recording (see 
Supplementary Methods for details). 
A synthetic luciferin, CycLuc1, has been shown in prior studies to offer better distribution throughout the 
body and greater light emissions at lower concentrations (Evans et al. 2014). We tested whether this 
synthetic luciferin could provide comparable or superior results to D-luciferin when delivered via an 
osmotic pump. CycLuc1 (produced in the lab of Dr. Stephen Miller, University of Massachusetts Medical 
School, Worcester, Massachusetts) was prepared in a 5 mM solution in sterile 0.1 M phosphate-buffered 
saline (PBS) and was mixed as for D-luciferin. Both 7-day and 14-day pumps were tested. 
The bioluminescence data was collected until day 9 for 7-day pumps and until day 11 or 12 for 14-day 
pumps. After removal, any residual volume remaining in pumps was measured to check against the 
expected rate of delivery, and any changes in the appearance of the solution were noted. Data files were 
truncated if necessary to remove measures taken after calculated pump depletion.  
Each animal underwent two minipump trials using the procedures described above. The two pump 
implantation surgeries were separated by 28 days and within each group of surgeries pump volumes were 
selected in a counterbalanced design. Each animal received the same substrate on both occasions, with 
only the pump type (7-day or 14-day) differing.  
Delivery of D-luciferin by drinking water  
A technically simple manner of substrate delivery is to provide the compound in the drinking water. A 
prior study suggested this approach of substrate delivery would be feasible (Hiler et al. 2006). This 
approach depends on the availability of a reasonably inexpensive substrate in appropriate amounts, 
solubility, acceptability by the mouse, and low toxicity. For our initial experiments, D-luciferin, potassium 
salt (LUCK-1G, GoldBio, St Louis, MO) was selected. Major advantages of this approach are the potential 
to conduct long-term studies with fresh solutions provided at regular intervals, and the avoidance of 
surgical procedures. A concern with administration of substrate in the drinking water is the possibility that 
the rhythmic behavior of drinking would lead to rhythmicity in substrate ingestion and availability, thus 
producing bioluminescence rhythms that reflect drinking behavior rather than reporter gene expression. 
This, however, is best addressed using mice with peak reporter expression at a different phase from peak 
drinking behavior, and is not addressed in the experiments reported here. 
To study dose-response to D-luciferin through drinking and reversibility, each mouse was tested for 
approximately 3 days at each concentration. We tested 10 mM, 0 mM, 1 mM, and 5 mM of D-luciferin, in 
that order. Solutions were made by dissolving powdered D-luciferin in water in 50 mL conical tubes, 
vortexing 1-2 minutes to dissolve particulate and then protected from light. Experiments were thereafter 
conducted in constant darkness. Drinking was monitored by measuring residual volume and all doses were 
equally tolerated by the mice tested. An additional 3 day experiment with 0 mM D-luciferin was conducted 
5 weeks later, to test baseline levels when it was certain that no substrate remained within the animal 
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after prior exposure. On the first day of this experiment as well as immediately prior to the recording 
conducted 5 weeks later, animals were anesthetized briefly (circa 5 min) in an induction chamber at 3% 
isoflurane followed by placement in a nose cone to allow shaving of back and stomach (see Supplementary 
Figure S3). 
Animals were put into the LumiCycle In Vivo unit at the end of the light portion of the 12:12 LD cycle and 
were thereafter recorded in constant darkness. The bottle of D-luciferin was changed to the new dose 
every 3 days between CT 6 and CT 11. Mice drank on average 3.9 mL/ day. 
To compare D-luciferin and CycLuc1 delivered in drinking water, four mice were tested using an ABA 
design with 0.1 mM D-luciferin, 0.1 mM CycLuc1, and a second treatment of 0.1 mM D-luciferin. 
Treatments were given for approximately 3 days each, with approximately 1 day with plain water available 
in between each treatment. Mice were given Cycluc1 for 4 days, due to a circa-1 day equipment failure 
during this experimental run. Bioluminescence was measured in DD using the LumiCycle In Vivo unit, and 
volume consumed was monitored by noting initial and final water volumes.  
 
Assessment of the source of bioluminescence by IVIS imaging 
 
mPer2LucSV/+ mice were allowed ad libitum access to drinking water containing D-luciferin (2 mM, n=10 or 
0.1 mM, n=6) or CycLuc1 (0.1 mM, n=10) for at least 12 hours before study.  Another group of animals 
(n=7) had water available and received D-luciferin by injection (0.1 mL of 10 mM, i.p.).  Animals were 
studied at clock times at which elevated bioluminescence was expected based on our previous studies 
(ZT15-21, van der Vinne et al., 2018). Mice were anesthetized with isoflurane, removed briefly to be 
shaved, and images were captured of ventral and dorsal views using Living Image software on an In Vivo 
Imaging System (IVIS-100, Caliper, now Perkin Elmer) in the UMass Medical School Small Animal Imaging 
Core Facility. After external imaging the animals were euthanized by decapitation while under anesthesia, 
and organs were dissected. Images of the dissected tissues were captured to assess the distribution of 
light coming from specific anatomical areas. Quantitative analysis of bioluminescence was performed 
using Living Image 4.4 software.   
To assess the distribution of bioluminescence among internal organs, values for each tissue were 
expressed as a percentage of the total signal from all identified anatomical areas. To accommodate 
inconsistencies in dissections, the signal from uterus, perigonadal fat and any dissected intra-abdominal 
adipose tissue were summed in females to a single value described called “fat”. In males, epididymal 
adipose tissue and any dissected intra-abdominal adipose tissue were summed to give a single value “fat”. 
Several tissues did not contribute substantially (<4%) to total signal and are lumped together as “other”. 
These tissues (and the number of observations leading to their assignment to this group) are: esophagus 
(16), stomach (44) lung (39), heart (40), thymus (32), spleen (41), testes (19), seminal vesicles (16), urinary 
bladder (24) brain (9), and head (40).  Values from the remaining carcass post-dissection were labeled 
“body”. 
 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 24, 2020. . https://doi.org/10.1101/2020.08.24.264531doi: bioRxiv preprint 
 7 
Data analysis 
All data were analyzed using RStudio, with the exception of the Bayesian MCMC analysis, which was run 
in MATLAB. Data files and R code are posted on Open Science Framework (Link for peer review purposes: 
https://osf.io/p3qke/?view_only=41db92d90ade49ea8c2db2537532ed11). A discrete wavelet transform 
(DWT) was applied to each time series to detrend and to calculate the rhythm phase using the wmtsa R 
package (https://cran.r-project.org/web/packages/wmtsa/index.html), as described in (Leise and 
Harrington 2011, Leise 2017). We applied the S12 filter on 15-min median binned data; medians were 
used to reduce the effect of large outliers. Data before the first trough and after the last trough were 
discarded to avoid edge effects. 
The signal-to-noise ratio (SNR) in decibels was calculated for 2-day windows, starting at the first trough 
(dropping most of the first day of recording), as 10 times the log10 of the ratio of the sum of squares of 
DWT circadian component D6 to the sum of squares of all DWT components at least 2 levels below the 
circadian scale (D1-D4). The level immediately below circadian (D5) contains an inseparable mix of 
circadian and noise energy, so was discarded. An SNR value above 0 indicates the signal is stronger than 
the noise (ratio was greater than 1). The SNR does not statistically test whether there is a significant 
circadian rhythm present, although a high SNR value strongly suggests it. A negative SNR value can mean 
either a rhythm swamped by noise or no rhythm (ratio of signal to noise energy was less than 1). 
The circadian energy is the sum of squares of the DWT circadian component D6 divided by the sum of 
squares of all DWT components D1-D6, yielding the proportion of total energy that is at the circadian 
scale, for the same window as the SNR. This proportion does not indicate whether there is a significant 
circadian rhythm present, although a value above 0.60 strongly suggests it. 
As a measure of uncertainty in whether the period can be determined from the data, we ran a Bayesian 
statistical analysis via MCMC sinusoid fitting, as described in (Cohen et al. 2012), for 4-day windows, 
dropping the first 24h of recording. The procedure generates a distribution of period estimates, where 
the 95% credible interval (CI) is the interval of most likely period values. A mean period estimate can also 
be obtained from this distribution. The CI provides evidence for whether the period of a time series can 
be reliably measured. The wider the CI, the less credible it is that the time series has a measurable 
circadian period. Only 14-day pump records were used for this computation, to have sufficient length. 
To assess the statistical significance of circadian rhythms in the data, JTK and Lomb-Scargle q-values (false-
discovery-rate adjusted p-values) were calculated using the MetaCycle R package (Wu et al. 2016), applied 
to 3-day windows, dropping the first 24h of the recording and using 90-min median binning to reduce 
correlated high-frequency noise and outliers.  
DWT peak times are the peaks in the circadian signal component of the bioluminescence obtained using 
the discrete wavelet transform. Time relative to projected lights indicate the DWT peak times in relation 
to the time of lights on (6 am) in the colony room where animals were housed prior to the in vivo 
bioluminescence experiments.  
Further experimental details are provided in the supplementary methods. 
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Results 
As in many previous reports (Saini et al. 2013, van der Vinne et al. 2018, Crosby et al. 2019), we were able 
to detect circadian rhythms of bioluminescence in vivo from mice carrying the mPer2Luc transgene (see 
Figure 1). Given that the reporter signal arises from multiple tissues (see below), this suggests that the 
tissues we are detecting express rhythms with some degree of synchrony even during housing in constant 
darkness. 
 
Figure 1. Example of bioluminescence data with 14-day D-luciferin pump (0.25 uL/h of 100 mM D-Luciferin), or 14-day CycLuc1 pump 
(0.25 uL/h of 5 mM CycLuc1). Top graph for each example: 15-minute median binned trace with counts/sec scale on the left and 
normalized scale on the right (subtract first percentile then divide by median, so min is mapped to zero and median mapped to 1; 
using first percentile reduces the effect of outliers). Bottom graph for each example: For the signal-to-noise ratio analysis, the DWT-
calculated circadian component D6 is treated as the signal and the summed components D1-D4 are treated as the noise. The data 
before the first trough and after the last trough are discarded to avoid edge effects. 
We first investigated bioluminescence rhythms in mice receiving D-luciferin continuously using an osmotic 
minipump (Figure 1). A 14-day pump delivers a smaller volume per h than a 7-day pump (0.25 uL/h vs 0.5 
ul/h, respectively) yet both pumps are limited to a 100ul reservoir. We asked if this reservoir, with 100 
mM D-luciferin, was able to lead to a detectable rhythm in bioluminescence, in a small sample of 4 mice. 
This experiment also tested the impact of holding D-luciferin solution at body temperature for up to 11-
12 days. Table 1 shows the results. One animal was noted to have unusually rapid fur regrowth and 
showed progressive signal loss (see Supplementary Figure S4C). Both rates of D-luciferin delivery led to 
detectable circadian rhythms in bioluminescence.  
In addition, we asked if the synthetic luciferase substrate, CycLuc1, can be effective at concentrations 
lower than that of D-luciferin, as previously seen in studies with acute injection of the substrates (Evans 
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et al. 2014). We tested 5 mM CycLuc1 in 7-day and 14-day osmotic minipumps, and again we detected 
circadian rhythms in bioluminescence (Figure 1). Traces for all 16 recordings (7- and 14-day pumps, both 
substrates) are given in Supplementary Figure S4. 
 
Table 1 - Summary of key measures of rhythms recorded from mice with osmotic pumps delivering substrate. See Methods for 
details. Peak time is given in hours with 0=midnight, using the peak nearest the day 2 mark. Prior housing room LD cycle had lights 
on 0600-1800 h. Median bioluminescence is for the first 3 days of recording. 
Table 1 provides a summary of the analysis of the osmotic minipump data. All but one animal had 
bioluminescence profiles that were significantly rhythmic according to both JTK and Lomb-Scargle tests. 
The exception is the one mouse with a 14-day D-luciferin recording mentioned above, for which hair 
regrowth was an issue. The Bayesian statistical analysis supports this assessment, yielding mean periods 
near 24 h and reasonable CI widths, given the shortness of the time series, again with the exception of 
the single problematic 14-day D-luciferin recording. The signal-to-noise ratio (SNR) varied, reflecting the 
high-amplitude noise present in many of these recordings; noise amplitude tended to increase greatly 
near signal peaks, as shown in Figures 1 and 2. While SNR values above 2 tend to allow greater precision 
in period and phase estimates, the analysis here suggests that even when noise levels are relatively high, 
the recordings are statistically rhythmic with measurable period and phase (though keeping in mind the 
uncertainty indicated by the Bayesian analysis). The circadian energy provides an alternative measure to 
the SNR for assessing signal strength. This measure largely agrees with the SNR results -- strong circadian 
signals tend to have SNR above 1.5 and circadian energy above 0.6. 
Next, we asked if we could measure rhythmic bioluminescence using delivery of substrate in the drinking 
water, and if the signal varied with the concentration of D-luciferin. As shown in Figure 2, we saw an 
increased median level of bioluminescence with increasing concentration of D-luciferin in the drinking 
water across the 4 mice tested, but the SNR was not reliably altered with dose. The 0 mM condition 
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immediately following the 10 mM concentration allowed us to observe the duration of wash-out (loss of 
signal following substrate removal). Also shown in Figure 2, residual signal was observed for variable 
amounts of time after D-luciferin (10 mM) withdrawal. Notably an additional 0 mM condition that was 
not immediately preceded by D-luciferin administration yielded a true baseline, with low levels of 
bioluminescence (with negative SNR and non-significant JTK and Lomb-Scargle q-values). All drinking 
water bioluminescence recordings are shown in Supplemental Figure S5. 
 
Figure 2 Example of bioluminescence data with D-luciferin delivered via drinking water, using a sequence of doses as indicated. 
Vertical lines indicate when substrate solutions were changed. 
We then asked if delivery of the synthetic substrate CycLuc1 in the drinking water would produce robust 
bioluminescence signal at lower concentrations of substrate, as previously reported (Evans et al. 2014). 
As shown in Figure 3, CycLuc1 treatment (0.1 mM) produced a stronger bioluminescence signal than the 
same concentration of D-luciferin in each of 4 animals. We found no consistent difference in the amount 
mice drank across conditions (Supplemental Figure S6). 
 
Figure 3.  Bioluminescence counts per day were calculated for each treatment by dividing the total sum of counts by the number of 
days. Treatments were 0.1mM D-Luciferin, 0.1mM CycLuc1, and 0.1mM D-Luciferin, and were 3 days in length with a day of plain water 
administered between treatments. 
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Bioluminescent rhythm damping (as seen e.g. in Figure S4G) might be attributable to fur regrowth in these 
black mice, and/or substrate degradation over time. We incubated aqueous solutions of D-luciferin and 
CycLuc1 for stability for multiple days at body temperature to determine their relative stability. Prolonged 
incubation of D-luciferin at 37 °C resulted in substantial oxidation of D-luciferin to dehydroluciferin as 
judged by LC-MS (see Supplementary Methods). After 14 days, ~50% of the D-luciferin had oxidized (Figure 
4). Some loss of D-luciferin by racemization to L-luciferin is also likely (Nakajima et al. 2020). 
Dehydroluciferin is not a luminogenic substrate for firefly luciferase, and is a much more potent inhibitor 
than L-luciferin  (da Silva and da Silva 2011). The ~6-fold decrease in bioluminescent signal observed when 
using this solution for in vivo imaging may thus reflect luciferase inhibition by dehydroluciferin as well as 
a reduction in the D-luciferin dose. By contrast, no formation of a dehydroluciferin product was noted for 
CycLuc1 at 37 °C or for either substrate incubated at 4 °C, and the in vivo imaging results were comparable 
to a freshly-prepared solution (Supplemental Figure S7).  
 
Figure 4. Evaluation of D-luciferin after incubation at body temperature. LC/MS and in vivo bioluminescence imaging with D-luciferin 
incubated in aqueous buffer at 37 °C for 0, 7, or 14 days.  
One shortcoming of assessing bioluminescence rhythms using the LumiCycle In Vivo is that this method 
does not provide information on the anatomical source of bioluminescence. Previous studies of 
Per2::Luc in mice conducted with bioluminescence imaging have identified the liver, kidneys, and 
submandibular gland as the primary sources of ‘signal’ from anesthetized mice (Tahara et al. 2012).  
Notably, in each of these studies, the substrate was provided by intraperitoneal injection. Thus, we 
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performed IVIS imaging studies to assess the sites of origin of bioluminescence in mPer2LucSV/+ mice 
receiving substrate in the drinking water.  
 
 
Figure 5. IVIS imaging to assess the source of bioluminescence in Per2LucSV/+ mice. Upper panel: Images show paired dorsal (A-D) and 
ventral (E-H) images from a representative male mouse from each treatment group. Mice were imaged after drinking 0.1 mM D-
luciferin (A: dorsal view, E: ventral view), 2 mM D-luciferin (B: dorsal view, F: ventral view) or CycLuc1 (0.1 mM; C: dorsal view, G: 
ventral view), or after injection of 0.1mL D-luciferin (10mM; D: dorsal view, H: ventral view). All images are adjusted to the 
bioluminescence scale bar shown at right.  Lower panel: Proportion of total bioluminescence in each tissue assessed by IVIS imaging 
after dissection is summarized by mean +/- SD.  
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Mice drinking D-luciferin (2 mM or 0.1 mM) or CycLuc1 (0.1 mM) had readily detectable bioluminescence 
signal, located predominantly in the upper abdomen (ventral view) or from the area on the dorsal surface 
corresponding to the abdomen (dorsal view) (see Figure 5). These regions contributed over 75% of 
photons within the region of interest containing the entire animal.  The anatomical pattern of labeling did 
not appear related to the treatment group. Bioluminescence (at much lower levels) was observed in a 
variable pattern in extra-abdominal sites, including hands, feet, mouth, throat (presumably 
submandibular gland) and where urine leaves the body (vulva in females, penis in males), and on the 
dorsal side, upper back and rump. Mice receiving D-luciferin by injection had a similar distribution, 
including the preponderance of labeling coming from the abdomen in both ventral and dorsal views. We 
compared the log of counts from either ventral or dorsal views across conditions and sex using ANOVA. 
We found a significant effect of treatment in each view (Ventral: F(3,25)=107.21, p<.001; Dorsal: 
F(3,20)=152.2, p<.001). Tukey contrasts showed bioluminescence was greatest in mice receiving D-
luciferin by injection (0.1 mL of 10 mM), followed by the two treatments CycLuc1 (0.1mM) and D-luciferin 
(2 mM) (no significant statistical difference between these) and finally by D-luciferin (0.1 mM). When 
considering the ventral view, we saw no significant effect of sex (F(1,25)=0.002, p=.96) but for the dorsal 
views we found a weak sex effect (F(1,20)=4.59, p=.0446; signal trended higher in males).  
 
To further localize the source of bioluminescence signal, mice were euthanized by cervical dislocation 
while anesthetized with isoflurane, and tissues were rapidly dissected, spread out on paper, and images 
were captured.  Luciferase activity is dependent upon temperature, ATP and oxygen, all of which would 
plummet rapidly after euthanasia.  Assuming that the decline in these constituents occurs at an equivalent 
rate in different tissues, we can infer the relative strength of signals during in vivo imaging, based on the 
pattern seen in dissected tissues. Bioluminescence signal was strongest from tissues of the 
gastrointestinal tract in all animals. The intestine, cecum and colon were highly but heterogeneously 
labeled, and together accounted for ~65% of counts.  The pancreas and mesenteric tissue were not readily 
separated and had similar signal intensity, so this was imaged as a single ROI (labeled “pancreas” in lower 
panel, Figure 5); this tissue contributed ~ 10% of signal.  Liver and kidney each contributed ~ 6%.  The only 
other regions that consistently had detectable signal were the remainder of the body (from which tissues 
had been removed), and adipose tissue (especially perigonadal fat), which also averaged ~ 4-6% of light 
output. Given these findings, we suspect that the presence of higher bioluminescence in the kidney region 
on the dorsal view of intact mice might be due, in large part, to the spinal column blocking 
bioluminescence arising from the abdomen. 
 
Considering the total light output from these tissues, combined with their anatomical location (and likely 
physical obstacles to bioluminescence detection in vivo), it appears that the major contributors to 
bioluminescence signal detected from ambulatory mice are gastrointestinal tissues (intestine, cecum and 
colon, and pancreas), and kidney (by virtue of its dorsal location). Unexpectedly, liver was not a major 
contributor to the bioluminescence signal. We did not observe an obvious difference in source of 
bioluminescence depending on the substrate or route of administration (see lower panel, Figure 5).  
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Discussion 
These studies extend prior work that established the feasibility of recording gene expression rhythms in 
vivo with bioluminescence. We have chosen to conduct initial studies with the most widely used animal 
model for circadian bioluminescence currently available, the mPer2Luc/Luc mouse with the reporter 
PER2::LUC. We used mice with two copies of the reporter allele to enhance signal output. Thus, success 
with this animal model likely sets the mark for the most we can achieve, with less light expected from 
animals with bioluminescence directed to specific organs. On the other hand, PER2::LUC may offer a 
noisier rhythmic signal than organ-specific reporters, because it is reporting from diverse sources of signal. 
These diverse sources must be somewhat coordinated, to detect circadian rhythms at the whole-animal 
level as reported here. This is consistent with data from reports assessing bioluminescence rhythms in 
anesthetized mice by IVIS imaging, in which rhythms of PER2::LUC bioluminescence were relatively 
synchronous across the tissues assessed (Tahara et al. 2012, van der Vinne et al. 2018). 
Our results indicate that luciferin substrates are effective for producing detectable bioluminescence 
rhythms when delivered either by drinking water or by osmotic minipump. The possibility that the daily 
drinking rhythm altered the phase and/or amplitude of the bioluminescence rhythm could not be 
excluded in the current study. Future studies should be conducted using mice with a circadian reporter 
with peak expression at a phase not coincident with the major time of voluntary water intake. In the 
studies here, phase was rather variable, perhaps not unexpected when using mice with a reporter 
expressed throughout the body. 
The synthetic luciferin, CycLuc1, offers advantages in terms of signal detection and stability. CycLuc1 has 
a lower Km for firefly luciferase than D-luciferin, and can be used effectively at lower doses (Evans et al. 
2014). The ability of this substrate to be used at lower concentrations and/or delivered at slower rates, 
could potentially overcome some of the limitations imposed by the small volume of minipump reservoirs. 
Use of CycLuc1 might offer the possibility for longer-term experiments, with multiple days of recording 
providing estimates of circadian period with increased precision (Cohen et al. 2012).  
Another consideration for long-term studies using implanted osmotic pumps is the aqueous stability of 
the luciferin substrate at body temperature. Oxidation of a luciferin to its respective dehydroluciferin 
reduces the luciferin concentration and also introduces a potent luciferase inhibitor. 
We explored several different analysis methods for assessing the strength of the rhythmic signal in the in 
vivo bioluminescence data. The signal-to-noise ratio can be useful for measuring improvements in 
reducing the high frequency noise to create a clearer circadian signal, as can the circadian energy measure. 
These two measures provide evidence toward whether the period and phase can be reliably estimated, 
but are not direct tests of rhythmicity. Similarly, the Bayesian statistical analysis provides a measure of 
how reliable the period estimate is, but is not a rhythmicity test. Finding an effective rhythmicity test 
proved to be challenging, due to the correlated nature of the high frequency noise which caused some 
tests to give spurious results. The two statistical tests that appeared to work most reliably were JTK_CYCLE 
and Lomb-Scargle, as implemented in MetaCycle (Wu et al. 2016), using 90-min bins to avoid the 
problematic effects of the high frequency noise. The general conclusion from the various methods is that 
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the in vivo methods are generating data with clear circadian rhythms for which period and phase can be 
estimated with reasonable precision, analogous to that for other data with a similar number of cycles. 
Our DWT peak pump results (Table 1) suggested a possible sex difference in the timing of the measured 
rhythms, yet our sample size did not allow firm conclusions. To explore potential DWT bioluminescence 
peak differences between whole body male and female mice expressing PER2::LUC, we applied our DWT 
analysis on a combined dataset including all osmotic minipump treatments presented in this study, and a 
group of controls from another recently published paper (van der Vinne et al. 2020) that studied metabolic 
consequences and PER2::LUC bioluminescence in mice lacking a functional central clock (Vgat-Cre+ 
Bmal1fl/f, experimental group). The control animals from this study (No Cre Bmal1fl/f Per2LucSV/+) are another 
translational reporter from the Per2 locus, similar to the mPer2Luc/Luc animals used for ambulatory 
recordings in the current study. Bioluminescence data were obtained in our lab using the same equipment 
and methods presented in this paper, with CycLuc1 substrate delivered at a 0.25 uL/h rate in 14-day 
pumps. The DWT peak analysis (Figure 6) showed more variation in DWT peak times in males than 
females. We did not apply statistical analyses since our dataset contained animals from two separate 
studies but future studies could determine if the difference suggested by Figure 6 is replicable. 
 
Figure 6. DWT peak circular plots. Plots show DWT peaks near day 2 mark. , 0=midnight; mice came from a colony room with lights on 
6am-6pm. Shaded grey area indicates lights off in the colony room. DWT peak marker times for data from mice with osmotic mini 
pumps. Circles placed in inner ring = 7-day pump, diamonds placed in outer ring = 14-day pumps, dark grey = mPer2Luc/Luc mice included 
in this study, light grey = mPer2 LucSV/+ controls (No Cre Bmal1fl/fl) from previous study (van der Vinne et al. 2020). Jitter (factor = 3) was 
added to the images to reveal overlapping data points.  
 
We were not able to find any studies describing sex differences in whole-body PER2::LUC 
bioluminescence. Some sex differences in in vitro bioluminescence of explant tissues have been studied. 
Amplitude of the PER2::LUC rhythm in the adrenal and liver is higher in male mice (Kuljis et al. 2013, 
Kloehn et al. 2016), and phase of liver and adrenal rhythms was phase advanced in male mice (Kuljis et al. 
2013). In vitro retinal PER2::LUC oscillations show no sex-dependent effects on amplitude, period, phase, 
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or rhythmic power (Calligaro et al. 2020). Sex differences in sleep and circadian variables may play an 
important role in application of circadian research on negative health impact of circadian disruption 
(Boivin et al. 2016, Yan and Silver 2016, Qian et al. 2019). 
Limitations. 
We have discovered several methodological concerns. Due to the impact of room temperature 
fluctuations on PMT noise, our technical approach requires either carefully controlled room temperature 
or (ideally) a method for correction of temperature-related noise on the PMTs. We solved this problem 
by collecting dark counts regularly and subtracting those measures. Cooled PMTs might offer further 
advantages.  
We initially attempted to study mice with E-mitter implantable telemetry probes (Starr Life Sciences) to 
monitor rhythms in body temperature simultaneously with bioluminescence. Unfortunately, when 
implanted in a mouse housed in a LumiCycle In Vivo unit, the telemetry probes created electronic noise 
that appeared as additional PMT signal especially when the mouse showed high levels of locomotor 
activity. We confirmed this conjecture by detecting rhythmic “bioluminescence” from a mouse with an 
implanted telemetry probe, but with no substrate delivered by pump or drinking water (data not shown). 
A different telemetry system might offer the ability to monitor body temperature and other rhythms. 
While the body temperature probes could not be used as intended, their presence in animals recovering 
from the subsequent osmotic pump implant surgery provided insight into the prolonged effects of general 
anesthesia in our mice. During recovery from surgery, we noted that the circadian rhythm in body 
temperature was disrupted for 1-2 days, similar to prior reports but for a longer duration (Shirey et al. 
2015). Based on these results, we allowed 3 days for colony room recovery after osmotic pump 
implantation surgery in the studies reported here. Alterations in the circadian rhythms in body 
temperature might interfere with the hypothesized role of body temperature rhythms to synchronize 
rhythms in gene expression in peripheral tissues (Brown et al. 2002, Buhr et al. 2010, Schibler et al. 2015). 
The 3-day recovery period is a significant portion of the period of pump life from the 7-day, emphasizing 
the need to find alternative routes of administration or substrates that can be more concentrated to 
accommodate the fixed minipump volume, thus allowing longer studies. Our use of drinking water to 
deliver luciferin allows us to avoid the use of anesthesia and surgery, thus avoiding these potential effects 
on body temperature rhythms.  
Cycles in skin pigmentation and hair regrowth after shaving of pigmented animals can interfere with 
bioluminescence imaging (Curtis et al. 2011) and should be considered when planning longer-term data 
collection. At the time of shaving, we noted variations in skin color and texture. Some animals exhibited 
a mottled skin color on both back and abdomen, with irregular patches of dark pigmentation. These 
variations likely arose from the stage of hair growth the mouse was in at the time of shaving, which does 
not take place uniformly across the animal but rather occurs in waves (Plikus and Chuong 2008). In some 
cases hair removal itself can cause more rapid hair regrowth, or the animal may have already been in an 
active stage of the hair regrowth cycle (Li et al. 2017). Future studies to address this may include crossing 
transgenes onto an albino background to avoid the pigmentation and possibly even avoid the need for 
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shaving. A hairless mouse might provide optimal background (Collaco and Geusz 2003, Izumi et al. 2017) 
although hairless mice might still have skin pigmentation and can show other alterations in their 
phenotype (Hoshino et al. 2017). Moreover, there are sex differences in the optical properties of murine 
skin to be considered in experimental design. Males show an increase in reflectance and scattering of the 
bioluminescent signal due to their generally thicker dermis (Calabro et al. 2011). Consequently, careful 
consideration of timing of shaving as well as hair regrowth patterns must be taken to ensure optimal 
bioluminescence recordings. As described, the variability of pigmentation and hair regrowth patterns 
might be very limiting when recording from a tissue-specific area. Future studies to optimize in vivo 
bioluminescence imaging may include crossing transgenes onto an albino background to avoid 
pigmentation. Both albino and hairless phenotypes arise from recessive alleles; generating reporter mice 
with either albino coat or hairlessness requires at least 2 generations of breeding and might preclude 
generating more complicated genetic combinations (Konger et al. 2016). 
Future directions 
We anticipate further developments that will continue to optimize this approach for study of the circadian 
system. We look forward to studies of mice with various bioluminescent reporters, other synthetic 
substrates, and varied delivery methods. It is key to develop tissue-specific circadian reporters, and 
substrates may then need to be developed with each target tissue in mind. Further innovation is possible 
as this method expands. We did not test other PMTs available but innovations here might allow better 
detection of signals. Note that although firefly luciferase emits green light at room temperature, this 
emission is red-shifted at 37 °C and further red-shifted by depth-dependent spectral differences in 
transmission through the body (Zhao et al. 2005). PMTs with increased sensitivity at long wavelengths 
may thus be desirable. We expect that further optimization of these methods is possible, but here we 
demonstrate a method that reliably detects circadian rhythms in bioluminescence from the mPer2Luc 
mouse.  
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Figure legends 
Figure 1. Example of bioluminescence data with 14-day D-luciferin pump (0.25 uL/h of 100 mM D-luciferin), 
or 14-day CycLuc1 pump (0.25 uL/h of 5 mM CycLuc1). Top graph for each example: 15-minute median 
binned trace with counts/sec scale on the left and normalized scale on the right (subtract first percentile 
then divide by median, so min is mapped to zero and median mapped to 1; using first percentile reduces 
the effect of outliers). Bottom graph for each example: For the signal-to-noise ratio analysis, the DWT-
calculated circadian component D6 is treated as the signal and the summed components D1-D4 are 
treated as the noise. The data before the first trough and after the last trough are discarded to avoid edge 
effects. 
Figure 2. Example of bioluminescence data with D-luciferin delivered via drinking water, using a 
sequence of doses as indicated. Vertical lines indicate when substrate solutions were changed. 
Figure 3.  Bioluminescence counts per day were calculated for each treatment by dividing the total sum 
of counts by the number of days. Treatments were 0.1 mM D-luciferin, 0.1 mM CycLuc1, and 0.1 mM D-
luciferin, and were 3 days in length with a day of plain water administered between treatments. 
Figure 4. Evaluation of D-luciferin after incubation at body temperature. LC/MS and in vivo 
bioluminescence imaging with D-luciferin incubated in aqueous buffer at 37 °C for 0, 7, or 14 days.  
Figure 5. IVIS imaging to assess the source of bioluminescence in Per2LucSV/+ mice. Upper panel: Images 
show paired dorsal (A-D) and ventral (E-H) images from a representative male mouse from each treatment 
group. Mice were imaged after drinking 0.1 mM D-luciferin (A: dorsal view, E: ventral view), 2 mM D-
luciferin (B: dorsal view, F: ventral view) or  CycLuc1 (0.1 mM; C: dorsal view, G: ventral view), or after 
injection of 0.1mL D-luciferin (10mM; D: dorsal view, H: ventral view). All images are adjusted to the 
bioluminescence scale bar shown at right.  Lower panel: Proportion of total bioluminescence in each tissue 
assessed by IVIS imaging after dissection is summarized by mean +/- SD.  
Figure 6. DWT peak circular plots. Plots show DWT peaks near day 2 mark.  0=midnight. Mice came from 
a colony room with lights on 6am-6pm. Shaded grey area indicates lights off in the colony room. DWT 
peak times for data from mice with osmotic mini pumps. Circles placed in inner ring = 7-day pump, 
diamonds placed in outer ring = 14-day pumps, dark grey = mPer2Luc/Luc mice included in this study, light 
grey = mPer2LucSV/+ controls (No Cre Bmal1fl/fl) from previous study (van der Vinne et al. 2020). Jitter (factor 
= 3) was added to the images to reveal overlapping data points.  
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Table 1 - Summary of key measures of rhythms recorded from mice with osmotic pumps delivering 
substrate. See Methods for details.  Peak time is given in hours with 0=midnight, using the peak nearest 
the day 2 mark. Prior housing room LD cycle had lights on 0600-1800 h. Median bioluminescence is for 
the first 3 days of recording. 
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Standard mouse cages measuring 7 1⁄2” x 11 1⁄2” x 5” (Ancare, Bellmore, NY) with 30 g TekFresh bedding 
were used for all experiments in the LumiCycle In Vivo units, with a few simple modifications. To minimize 
obstruction in the field of view of the PMTs, cage lids were modified by removing the divider that normally 
contains chow. Chow (Teklad 2014) was available in a stainless-steel hopper (Ancare) side-mounted inside 
the cage. An aluminum bar measuring 4” x 1” x 5/8” was placed under the hopper to keep mice from 
nesting beneath. Reduced height square water bottles (Ancare) with #6 stoppers allowed the cages to be 
moved easily in and out of the unit. For delivery of a substrate in drinking water, 50 mL conical tubes were 
used instead of water bottles, also with # 6 stoppers. To ensure the availability of the solution through 
the stopper, the angle of the tubes was kept constant by an extension spring clipped to the cage lid (See 
Supplementary Figure 2). We recorded general locomotor activity by a passive infrared motion sensor 
using Clocklab software (RRID:SCR_014309). 
Possible sources of background noise include the type of bedding and the composition of the diet. To rule 
out these possible contributors in our system we tested an empty cage as well as ones bedded with Aspen 
bedding, white crinkled paper, and two amounts of TekFresh (7099, Envigo). The lesser amount of 
TekFresh was closest to the level of the empty cage and all subsequent experiments used that amount. 
To avoid abdominal autofluorescence as reported (Inoue et al. 2008) we used a global, alfalfa-free diet 
(Teklad 2014, Envigo). We did a further comparison between that and a purified diet (AIN-93M, Envigo) 
and found no significant difference between the two in our system.   
Pump Preparation 
Alzet® subcutaneous osmotic minipumps (Durect, Cupertino, CA), calibrated to deliver for either 7 or 14 
days were used. On the day prior to implantation, pumps were filled with substrate which had been 
sterile-filtered using 1 mL Luer Slip syringes (Grainger Industrial Supply, Springfield, MA) and Millipore 
syringe filters (Thermo Fisher Scientific, Waltham, MA). 0.5cc BD Insulin Syringes with no residual volume 
(MWI Veterinary Supply, Boise, ID) were used to fill the pumps. To measure the final volume in the filled 
pump, each pump, flow moderator, and packaging was weighed before and after filling. Weights were 
recorded to determine initial filled volume and to compare with the residual volume at the end of 
treatment, to measure the actual delivered dose. Pumps were then primed for up to 24 hours in 1.5 mL 
sterile saline in 15 mL conical tubes, at 37° C.  
Surgery for Pump Implantation  
One hour prior to surgery animals were weighed and injected subcutaneously with buprenorphine (0.05 
mg/kg) and either ketoprofen (5 mg/kg) or meloxicam (2 mg/kg) as analgesics. At the beginning of surgery 
animals were placed in an induction chamber with 3% isoflurane, then transferred to a nose cone. Body 
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temperature was maintained with a heated gel pack placed under the animal throughout surgery. Eyes 
were protected with veterinary ophthalmic ointment and anesthesia was maintained at 2.5% to 3%.  
Animals were shaved with an OsterFinisher clipper (Osterpro.com) on the back, from shoulder blades to 
pelvic bones, and around both sides and the complete abdomen (See Supplementary Figure 3). After 
washes with Betadine and 70% EtOH and using sterile surgical technique, a ~10 mm skin incision with a 
#15 scalpel was made below the shoulder blade, perpendicular to the spine. A 20 mm subcutaneous 
pocket was created using a blunt hemostat and flushed with 0.5 mL sterile saline. Pumps were removed 
from the priming solution and inserted into the pocket. Incision was closed with 3-4 absorbable sutures 
(Ethicon #023434, MWI Veterinary Supply, Boise ID) and treated with a splash block (Lidocaine 0.2%, 
Bupivicaine 0.05%) and antibacterial ointment (Vetropolycin, MWI Veterinary Supply). 
During recovery animals were housed individually in large standard mouse cages (10 1⁄2” x 19” x 6 1⁄8”, 
fitted with Micro Filter Top™, Ancare) with TekFresh bedding. Cages were placed on top of heated discs 
(SnuggleSafe.com) overnight and animals monitored for recovery and freedom of movement. Besides 
normal chow ad libitum and water, soft food and apple slices were placed in dishes on the cage floor. 
After three days recovery in 12:12 LD, animals were moved into smaller standard cages and placed into 
individual LumiCycle In Vivo units in constant darkness, just prior to the time of lights off in 12:12 LD. Data 
were recorded for 7 days in DD, and animals were checked once a day at randomized times using an 
infrared viewer. As well as bioluminescence, locomotor activity was recorded throughout the experiment 
with a passive infrared motion sensor using ClockLab (Actimetrics). After completing the pump 
experiments, animals were euthanized and tissue samples were collected for confirmation of genotype.  
Surgery for Pump Removal  
For those experiments in which an animal was to be tested with a second pump after recovery, a pump 
removal protocol was followed. Animals were briefly anesthetized with 3% isoflurane in an induction 
chamber, to allow for subsequent subcutaneous injections of buprenorphine and ketamine or meloxicam 
as previously described, without restraint. Animals were returned to their home cages for at least 30 
minutes before beginning surgery. An additional brief induction followed by transfer to a nose cone 
preceded the pump removal and body heat was again maintained with a gelpack. Any remaining sutures 
were removed and an incision was made in the original site or parallel to it, depending on the degree of 
healing present. The pump was removed, the subcutaneous pocket flushed with 0.5 mL saline and incision 
closed as for pump insertion. Postoperative care was the same as for pump insertion. 
Dose determination 
Immediately following a pump removal, any remaining substrate was removed from the pump using a 0.5 
cc BD Insulin Syringe. Actual dose delivered was calculated by the following formula, as provided by the 
manufacturer Alzet: 
Mean Pumping Rate x Infusion Duration (in hours) = Volume Infused. 
Actual Fill Volume – Volume Infused = Residual Volume 
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During the hours of priming before surgical implantation in the animals, the rate per hour was calculated 
at half the mean pumping rate. From the time of implant until removal the rate was calculated at the 
normal pumping rate. 
Thermal stability of luciferins 
D-luciferin sodium salt was purchased from GoldBio. CycLuc1 was synthesized as previously described 
(Reddy et al. 2010). The luciferin substrates were dissolved in PBS to a final concentration of 100 mM (D-
luciferin) and 5 mM (CycLuc1), then incubated at 4 °C or 37 °C for the indicated time (0-14 days). 
Aliquots were removed for LC-MS and bioluminescence imaging comparisons.  
 
FVB/NJ mice were purchased from Jackson Laboratories (Bar Harbor, ME). Intravenous injection of 
AAV9-CMV-WTluc2 was performed as previously described (Mofford et al. 2015). Bioluminescence 
assays were performed on a Xenogen IVIS-100 system in the UMass Medical School Small Animal 
Imaging facility. All luciferin aliquots were sterile-filtered through a 0.22 μm syringe filter (Millex-GV) 
prior to injection. Each mouse was weighed to determine substrate dosing and anesthetized using 2.5% 
isoflurane in 1 L/min oxygen. Each luciferin substrate was injected i.p. at a dose of 4 μL/g mouse and 
mice were imaged ventrally 12 minutes after injection. Data acquisition and analysis were performed 
with Living Image® software. Data were plotted and analyzed with GraphPad Prism 7, and reported as 
the total flux (p/s) for the whole mouse. All these experiments were conducted in accordance with the 
Institutional Animal Care and Use Committee of The University of Massachusetts Medical School (docket 
#A-2474-14). 
 
LC-MS analyses were performed on an Agilent Technologies 6130 quadrupole LC-MS connected to an 
Agilent diode array detector. Chromatography was conducted on an Agilent InfinityLab Poroshell 120 
EC-C18 column (4.6 x 50 mm, 2.7 micron particle size), with a mobile phase of water/acetonitrile with 
0.1% formic acid. Samples were prepared by dilution of an aliquot of the 100 mM and 5 mM PBS stocks 
with Milli-Q water to 500 μM D-luciferin and 250 μM CycLuc1, respectively. Of this solution, 20 μL was 
injected onto the C18 column, and a gradient of H2O and acetonitrile (+0.1% formic acid) was used as 










2	 100	 0	 1.0	 600	
10	 0	 100	 1.0	 600	
12	 100	 0	 1.0	 600	
14	 100	 0	 1.0	 600	
  
 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 24, 2020. . https://doi.org/10.1101/2020.08.24.264531doi: bioRxiv preprint 
 32 
Materials 
Name Company Catalog Number 
D-Luciferin Potassium Salt GoldBio Catalog # LUCK-1G 
CycLuc1  gift of Dr. Steve Miller  
Alzet osmotic minipumps 7 day Durect Model 1007D Cat # 0000290 
Alzet osmotic minipumps 14 
day Durect Model 1002 Cat #0004317 
Luer slip syringes Grainger Industrial Supply 
Item # 19G334 Mfr. Model # 
4010.200V0 
Millipore syringe filters Thermo Fisher Scientific CAT # SLGV004SL 
0.5cc BD Insulin Syringes MWI Veterinary Supply MWI SKU: 19545 
Vetropolycin Antibiotic 
Ointment MWI Veterinary Supply MWI SKU: 001479 
Oster Finisher clipper OsterPro.com 
Oster® Finisher® Trimmer (Model 
59) 
Ethicon Absorbable sutures MWI Veterinary Supply Cat # 023434 
Recovery cage Ancare N40 
Recovery cage heat discs SnuggleSafe Microwave heat pad 
Micro Filter Top Ancare N40 Micro Filter Top 
Recording cage Ancare N10 
Reduced Height Square water 
bottle Ancare Reduced Height Square Bottle 
Food hopper Ancare Mouse Feeder 
Carson OPMOD DNV viewer www.opticsplanet.com 99-NV-OPMOD-DNV-DN-300 
Pulsar Edge Night Vision 
Goggles www.nightgearstore.com PU-75095 
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Supplementary Figure captions: 
Figure S1. The LumiCycle In Vivo System, single unit 
Figure S2. Standard cage and accessories (A) Standard mouse cage, food hopper, aluminum bar, reduced 
height water bottle or conical tube and extension spring to maintain angle for small volume solutions. 
(B) Aluminum bar is placed underneath food hopper to prevent nesting and to maximize visible range of 
PMTs. (C) Cage assembly with reduced height water bottle. (D) Cage assembly with conical tube and 
extension spring to maintain angle of tube when using low volumes of substrate solutions. 
Figure S3. Drawing to demonstrate the extent of the shave administered prior to experiments. The 
mouse was shaved in a band that extended from dorsal to ventral surface. 
Figure S4. All results  of bioluminescence data with either 7-day or 14-day D-luciferin or CycLuc1 pumps. 
Top graph for each example: 15-minute median binned trace with counts/sec scale on the left and 
normalized scale on the right (subtract first percentile then divide by median, so min is mapped to zero 
and median mapped to 1; using first percentile reduces the effect of outliers). Bottom graph for each 
example: For the signal-to-noise ratio analysis, the DWT-calculated circadian component D6 is treated as 
the signal and the summed components D1-D4 are treated as the noise. The data before the first trough 
and after the last trough are discarded to avoid edge effects. The 14 day pumps delivered 0.25 uL/h of 
100 mM D-Luciferin or 5 mM CycLuc1. The 7 day pumps delivered 0.50 uL/h of 100 mM D-Luciferin or 5 
mM CycLuc1 (blue - D-luciferin pumps, red- CycLuc1 pumps). Individual animals are identified by the 
“IVMxx” number. 
Figure S5. All drinking dose response data. Individual animals are identified by the “IVMxx” number. 
Final data for IVM 89 (D) was lost due to equipment failure.  
Figure S6. A) Drinking rate results for CycLuc1 vs D-luciferin comparison data. Drinking rate per day for 
each treatment was calculated by dividing the total volume of substrate consumed by the number of 
days. B) Bioluminescence records for all animals (Left - 0.1 mM D-Luciferin treatment 1, center - 0.1 mM 
CycLuc1 treatment, right - 0.1 mM D-Luciferin treatment 2). Individual animals are identified by the 
“IVMxx” number.  
Figure S7. Evaluation of D-luciferin and CycLuc1 after incubation at 4 °C or 37 °C. LC/MS and in vivo 
bioluminescence imaging after incubation in aqueous buffer at the specified temperature for 0, 7, or 14 
days in FVB/NJ mice previously receiving iv injection of AAV9-CMV-WTluc2 as previously described 
(Mofford et al. 2015).  
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